Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages 9065-9070

  Lu, Yao Ping ^a,b   Lou, You Rong ^a   Bernard, Jamie J ^c   Peng, Qing Yun ^a   Li, Tao ^a   Lin, Yong ^b,d   Shih, Weichung Joe ^b,d   Nghiem, Paul ^e   Shapses, Sue ^f   Wagner, George C ^c   Conney, Allan H ^a,b,g  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f RUTGERS UNIVERSITY   (United States)

^g GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Obesity; Skin cancer

Indexed keywords

ADIPOCYTOKINE; CASPASE 3; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SERINE PROTEINASE INHIBITOR; SERPIN E1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER SURGERY; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; FEMALE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; LIPECTOMY; LIPID DIET; LOW FAT DIET; MOUSE; NONHUMAN; PARAMETRIAL FAT PAD; PARTIAL LIPECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; ULTRAVIOLET B RADIATION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CASPASE 3; DIET, HIGH-FAT; FEMALE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; LIPECTOMY; MICE; NEOPLASMS, RADIATION-INDUCED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ULTRAVIOLET RAYS;

MUS;

EID: 84861863986     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205810109     Document Type: Article

References (56)

1. Kripke ML (1986) Sunlight and skin cancer. Tex Med 82:52-53.
2. Stern RS, Weinstein MC, Baker SG (1986) Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol 122:537-545. (Pubitemid 16090916)
3. Jemal A, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
4. Rogers HW, et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-287.
5. Lu Y-P, et al. (2001) Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): Relationship to decreased tissue fat. Cancer Res 61:5002-5009. (Pubitemid 32681527)
6. Lou YR, Lu YP, Xie JG, Huang MT, Conney AH (1999) Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in highrisk SKH-1 mice previously treated with ultraviolet B light. Nutr Cancer 33:146-153.
7. Michna L, Lu YP, Lou YR, Wagner GC, Conney AH (2003) Stimulatory effect of oral administration of green tea and caffeine on locomotor activity in SKH-1 mice. Life Sci 73:1383-1392. (Pubitemid 36794582)
8. Michna L, et al. (2006) Inhibitory effects of voluntary running wheel exercise on UVBinduced skin carcinogenesis in SKH-1 mice. Carcinogenesis 27:2108-2115. (Pubitemid 44530585)
9. Lu YP, et al. (2007) Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice. Proc Natl Acad Sci USA 104:12936-12941.
10. Lu Y-P, et al. (2012) Oral caffeine during voluntary exercise markedly inhibits skin carcinogenesis and decreases cytokines associated with inflammation in UVB-treated mice. 103rd Annual Meeting of the American Association for Cancer Research, Chicago, Abstract 4286.
11. Lu YP, et al. (2006) Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice. Proc Natl Acad Sci USA 103:16301-16306.
12. Lou YR, et al. (2011) Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 32: 1078-1084.
13. Baumann CA, Rusch HP (1939) Effect of diet on tumors induced by ultraviolet light. Am J Cancer 35:213-221.
14. Black HS, Lenger W, Phelps AW, Thornby JI (1983) Influence of dietary lipid upon ultraviolet-light carcinogenesis. Nutr Cancer 5:59-68. (Pubitemid 14205630)
15. Black HS (1998) Influence of dietary factors on actinically-induced skin cancer. Mutat Res 422:185-190.
16. Black HS, et al. (1994) Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med 330:1272-1275. (Pubitemid 24129960)
17. Black HS, Lenger WA, Gerguis J, Thornby JI (1985) Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis. Cancer Res 45:6254-6259. (Pubitemid 16191551)
18. Ibiebele TI, et al. (2007) Dietary pattern in association with squamous cell carcinoma of the skin: A prospective study. Am J Clin Nutr 85:1401-1408. (Pubitemid 46740485)
19. Ibiebele TI, van der Pols JC, Hughes MC, Marks GC, Green AC (2009) Dietary fat intake and risk of skin cancer: A prospective study in Australian adults. Int J Cancer 125: 1678-1684.
20. Juge-Aubry CE, Henrichot E, Meier CA (2005) Adipose tissue: A regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19:547-566. (Pubitemid 41823815)
21. Kelley DE, et al. (2001) Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 86:5412-5419. (Pubitemid 33070268)
22. Baillargeon J, Rose DP (2006) Obesity, adipokines, and prostate cancer (review). Int J Oncol 28:737-745.
23. Berstein LM (2005) Hormones of adipose tissue (adipocytokines): Ontogenetic and oncologic aspects. Adv Gerontol 16:51-64.
24. Ogunwobi O, Mutungi G, Beales IL (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147:4505-4516. (Pubitemid 44268402)
25. Ogunwobi OO, Beales IL (2006) Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 134:105-113.
26. Ogunwobi OO, Beales IL (2007) The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 22:401-409. (Pubitemid 46336244)
27. Iyengar P, et al. (2003) Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22:6408-6423. (Pubitemid 37281689)
28. Chirco R, Liu XW, Jung KK, Kim HR (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25:99-113. (Pubitemid 43723986)
29. Guedez L, et al. (1998) In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102:2002-2010. (Pubitemid 29001847)
30. Li G, Fridman R, Kim HR (1999) Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59:6267-6275. (Pubitemid 30035652)
31. Murphy F, et al. (2004) N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol 3(Suppl 1):S8.
32. Liu XW, et al. (2005) Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: A potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res 65:898-906.
33. Nakopoulou L, et al. (2002) Enhanced mRNA expression of tissue inhibitor of metalloproteinase- 1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis. J Pathol 197:307-313. (Pubitemid 34778300)
34. Würtz SO, Schrohl AS, Mouridsen H, Brünner N (2008) TIMP-1 as a tumor marker in breast cancer-an update. Acta Oncol 47:580-590.
35. Wu ZS, et al. (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 122:2050-2056.
36. Davidsen ML, et al. (2006) TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. Br J Cancer 95:1114-1120. (Pubitemid 44606841)
37. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29-32.
38. Luparello C, Avanzato G, Carella C, Pucci-Minafra I (1999) Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat 54:235-244. (Pubitemid 29322346)
39. Chavey C, et al. (2003) Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278: 11888-11896. (Pubitemid 36800160)
40. Alexander CM, Selvarajan S, Mudgett J, Werb Z (2001) Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 152:693-703. (Pubitemid 34280155)
41. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E (2003) Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 89:249-255. (Pubitemid 36227275)
42. O'Grady A, et al. (2007) Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: Implications for tumour progression. Histopathology 51:793-804. (Pubitemid 350179420)
43. Kang R, et al. (2010) The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 17:666-676.
44. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100:7265-7270. (Pubitemid 36706427)
45. Shi CL, et al. (2011) Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3. Asian Pac J Cancer Prev 12:555-559.
46. Fujimoto H, et al. (2009) Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284.
47. Cai Z, et al. (2009) Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia 11:228-236.
48. Lu Y, et al. (2009) Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis 26:161-169.
49. Gao S, et al. (2010) Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa. Genes Chromosomes Cancer 49:526-538.
50. Wood IS, Wang B, Jenkins JR, Trayhurn P (2005) The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun 337:422-429. (Pubitemid 41429301)
51. Rocha VZ, et al. (2008) Interferon-gamma, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circ Res 103:467-476.
52. Weisberg SP, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808. (Pubitemid 38063703)
53. Xu H, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830. (Pubitemid 38063705)
54. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR (2002) Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51:1093-1101. (Pubitemid 34438355)
55. de Meijer VE, Sverdlov DY, Le HD, Popov Y, Puder M (2012) Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol Res, 10.1111/j.1872-034X.2011.00960.x.
56. Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV (2005) Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids. Cancer Res 65:8022-8027. (Pubitemid 41297283)